AlphaFold predicted structure
DCXR · Q7Z4W1

Mean pLDDT
96.3/ 100
Very high
244 residues
Confidence breakdown
- Very high(≥ 90)93%
- Confident(70–90)7%
- Low(50–70)1%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
dicarbonyl and L-xylulose reductase
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Likely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
pentosuria
neurodegenerative disease
autoimmune disorder of central nervous system
Disorder of carbohydrate metabolism
Age-related cataract
senile cataract
breast cancer
metabolic syndrome
breast carcinoma
Abnormality of the skeletal system
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
L-xylulose reductase
Catalyzes the NADPH-dependent reduction of several pentoses, tetroses, trioses, alpha-dicarbonyl compounds and L-xylulose (PubMed:11882650, PubMed:19337691, PubMed:40737316). Can use both NAD and NADP as cosubstrate but shows higher activity with NADP (PubMed:11882650). Participates in the uronate cycle of glucose metabolism (PubMed:11882650). May play a role in the water absorption and cellular osmoregulation in the proximal renal tubules by producing xylitol, an osmolyte, thereby preventing osmolytic stress from occurring in the renal tubules (PubMed:11882650)
DCXR · Q7Z4W1

Mean pLDDT
96.3/ 100
Very high
244 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0